2012 ANNUAL REPORT

32

Dear Colleagues:

2012 was a record-breaking year for ACCP! The 2012 Annual Meeting, held Sept. 23rd – 25th in San Diego, was a huge success as ACCP hosted its largest Annual Meeting in the history of the organization! Three days of exceptional educational Symposia, preceded by a day of Pre-meeting Workshops, ensured that ACCP maintained its reputation for excellence in Continuing Education. Attendees from around the world joined us to participate as keynote speakers, faculty, attendees, award winners, poster presenters and exhibitors. Building on this level of participation year after year will permit ACCP to continue to provide the highest quality of educational content and interaction.

The College continues to strive to meet Member requirements as processes are enhanced and evolve to provide value. We proudly launched the new eJournal, Clinical Pharmacology in Drug Development, in late 2011, publishing four issues in 2012. In Q4 2012, ACCP announced its publishing partnership with Wiley Periodicals Inc, as well as its intent to publish The Journal of Clinical Pharmacology in electronic format only to better meet the needs of an ever-increasing electronic world. The Learning Management System was more effectively utilized to provide ease of access to materials and post-event testing for meeting attendees. In order to better meet the needs of Members, functionality was enhanced in ACCP’s communications and membership database systems. The website continues to evolve to provide valuable resources for Student & Trainee needs, career search tools and grants & funding opportunities. Social media outreach continues to grow and we have now exceeded our original goals for the number of clinical pharmacology professionals following us on both Facebook and LinkedIn.

We look forward to 2013 with great anticipation. As we continue to evolve, ACCP remains committed to its strategic goals and to supplementing recent initiatives with new efforts to meet Members’ needs. Our goal is to establish ACCP as a leading organization in clinical pharmacology and related scientific disciplines. We look forward to seeing you in Bethesda, Sept. 22nd – 24th, at the 2013 ACCP Annual Meeting, “Clinical Pharmacology in Optimizing Drug Development and Therapeutics.” Make ACCP your membership organization of choice for Continuing Education, networking and staying current on all matters clinical pharmacology-related.

Sincerely,

Lisa L. von Moltke, MD, FCPPresident

2012 ANNUAL REPORT

3

President

Lisa L. von Moltke, MD, FCPGenzyme

President-elect Bernd Meibohm, PhD, FCP University of Tennessee

Secretary John van den Anker, MD, PhD, FCP Children’s National Medical Center

Treasurer Michael W. Jann, PharmD, FCP University of North Texas System College of Pharmacy

Immediate Past President Michael J. Fossler, Jr., PharmD, PhD, FCP GlaxoSmithKline

ACCP Officers 2012 – 2014 ACCP Current Regents

Vikram Arya, PhD, FCP Silver Spring, MD

Joseph S. Bertino, Jr., PharmD, FCP Schenectady, NY

James F. Burris, MD, FCP Washington, DC

Guenther Hochhaus, PhD, FCP Gainesville, FL

Joan Korth-Bradley, PharmD, PhD, FCP Collegeville, PA

Nancy A. Lass, MD, FAAP, FCP, LLD Westchester, IL

Diane R. Mould, PhD, FCP Phoenixville, PA

Marc Pfister, MD, FCP Bridgewater, NJ

Peter H. Wiernik, MD, FCP Chappaqua, NY

Honghui Zhou, PhD, FCP Malvern, PA

To improve health by optimizing therapeutics;Provide innovative leadership and interdisciplinary education that will enable the generation, integration and translation of scientific knowledge to optimize research, development and

utilization of medication for the benefit of all.

V IS ION & MISSION

Public Support & Other Revenue

1. Journal Revenue $ 743,515 45.1%

2. Annual Meeting $ 352,656 21.4%

3. Investment Returns $ 360,144 21.9%

4. Contributions $ 1,100 0.1%

5. Membership Dues $ 185,848 11.3%

6. Miscellaneous $ 4,468 0.3%

7. Net assets released from restriction $ 500 0.0%

Total Revenue $1,648,231

Statement of Activities

2012 ANNUAL REPORT

54

45.1

21.4 21.9

0.111.3

0.3 0.00%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

1 2 3 4 5 6 7

25.0

56.9

15.32.1 0.1 0.2 0.3

0%

10%

20%

30%

40%

50%

60%

1 2 3 4 5 6 7

Expenses

1. Program Expenses $ 274,757 25.0%

2. Administrative $ 624,559 56.9%

3. Journal-related $ 168,219 15.3%

4. Regents-related $ 23,485 2.1%

5. Membership-related $ 1,260 0.1%

6. Awards Program $ 2,500 0.2%

7. Fundraising $ 2,832 0.3%

Total Expenses $1,097,612

NET INCOME $ 550,619

1. Journal Revenue $ 743,515 45.1%

2. Annual Meeting $ 352,656 21.4%

3. Investment Returns $ 360,144 21.9%

4. Contributions $ 1,100 0.1%

5. Membership Dues $ 185,848 11.3%

6. Miscellaneous $ 4,468 0.3%

7. Net assets released from restriction $ 500 0.0%

Total Revenue $1,648,231

Statement of Activities (continued)

2012 ANNUAL REPORT

5

45.1

21.4 21.9

0.111.3

0.3 0.00%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

1 2 3 4 5 6 7

25.0

56.9

15.32.1 0.1 0.2 0.3

0%

10%

20%

30%

40%

50%

60%

1 2 3 4 5 6 7

2012 ANNUAL REPORT

76

Academic Medical Center

Pharma

Biotech

Consultant

Government

Hospital

CRO

Private Practice

Other

PhD

MD

Master’s

PharmD

Other

Distribution of ACCP Membership by Organizational Affiliation

Distribution of Membership by Degree

Continuing Education

ACCP seeks to promote the rational use of medications in humans through innovative research, development and regulation of medications, and education of healthcare professionals and patients on the optimal utilization of medications. ACCP’s Mission is to provide innovative leadership and interdisciplinary education that will enable the generation, integration and translation of scientific knowledge to optimize research, development and utilization of medication for the benefit of all.

ACCP is an accredited provider of Continuing Medical Education (CME) and Continuing Pharmacy Education (CPE). The educational offerings available in ACCP’s Learning Management System have been developed to fulfill the Continuing Education needs of a broad range of clinicians, including physicians, pharmacists, nurses, nurse practitioners, physician assistants, and clinical research coordinators and managers. The goal of these Continuing Education offerings is to improve the optimal development and use of therapeutics, with a specific concentration on clinical pharmacology.

Within clinical pharmacology, ACCP offers and seeks to develop educational programs focused on:

• Translational Medicine• Biomarkers• Clinical Pharmacokinetics and Pharmacodynamics• Applications of Quantitative Methodologies• Intrinsic and Extrinsic Factors that can affect Exposure-Response• Therapeutic Biologics• Pharmacoepidemiology / Pharmacogenomics• Pharmacoeconomics / Disease Management• Therapeutic Drug Monitoring• Novel Clinical Trial Designs• Experimental Pharmacology in In Vitro and In Vivo Studies• Decision Making in Research and Development

CME or CPE credit is available for many of the College’s Continuing Education offerings. Receipt of credit requires registration, and certificates of completion for each offering are available following satisfactory completion of a post-event test specific to each offering.

2012 ANNUAL REPORT

7

Annual Meetings

The 2012 ACCP Annual Meeting, held Sept. 23rd – 25th in San Diego, was the largest meeting in ACCP history! Consistent with tradition, a series of exceptional Pre-meeting Workshops and Symposia brought together a global audience for a meeting that was fast-paced and informative, but also maintained the intimate nature that the ACCP Annual Meeting is noted for, permitting attendees to have a high quality of networking and interaction on all levels.

Keynote Speakers included William J. Jusko, PhD, SUNY Distinguished Professor & Chair of Pharmaceutical Sciences, who spoke on “Moving PK/PD from Basic Towards Systems Pharmacology” and Michael Reed Barratt, MD, MS, NASA Astronaut, Director of Human Research Program, NASA Johnson Space Center, who addressed the audience on “Space Medicine: The Real McCoy”.

2012 ANNUAL REPORT

98

2013 Annual MeetingAmerican College of Clinical Pharmacology

Clinical Pharmacology in Optimizing Drug Development and Therapeutics

September 22 – 24, 2013Bethesda North Marriott Hotel & Conference Center, Bethesda, MD

Co-chairs: Vikram Arya, PhD and Honghui Zhou, PhD

Final Program

2013 ACCP Annual Meeting Program

2012 ANNUAL REPORT

9

Annual Meetings (continued)

Recognition Award Winners were as follows:

Distinguished Investigator Award – William J. Jusko, PhD, Distinguished Professor & Chair of Pharmaceutical Sciences, University at Buffalo, State University of New York

Honorary Fellowship Award – Charles Williams Flexner, MD, Professor, Medicine and Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine

Nathaniel T. Kwit Memorial Distinguished Service Award – Michael D. Reed, PharmD, FCCP, FCP, Associate Chair, Department of Pediatrics, Children’s Hospital Medical Center of Akron

Tanabe Young Investigator Award – Sriram Krishnaswami, PhD, FCP, Director, Clinical Pharmacology Specialty Care, Pfizer Inc

McKeen Cattell Memorial Award – Joseph Kovalchin, PhD, Senior Scientist, In Vivo Pharmacology, Eleven Biotherapeutics

Additionally, eight Student & Trainee Abstract Awards were given to:

•SungKweon(Ted)Cho

•DanielaJoiceConrado

•PriyankaJadhav

•JiaKang

•DonghwanLee

•SnehaNayadu

•WanSun

•LeiWu

Dr. Xiaoming Wang received the New Member Abstract Award and Dr. Daniela Joice Conrado was recipient of the Wayne A. Colburn Memorial Award. We look forward with great anticipation to the 2013 ACCP Annual Meeting, “Clinical Pharmacology in Optimizing Drug Development and Therapeutics,” to be held Sept. 22nd – 24th, 2013 at the Bethesda North Marriott Hotel & Conference Center in Bethesda, MD.

2012 ANNUAL REPORT

1110

Clinical Pharmacology in Drug Development

Clinical Pharmacology in Drug Development (CPDD) is an international, peer-reviewed, online-only journal focused on publishing high quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in early development phases in healthy subjects. Acceptance of a manuscript in CPDD will be determined by scientific rigor and technical soundness rather than perceived importance of the presented results. Thus, negative study results are explicitly not an obstacle for positive acceptance decisions. Only original research papers can be submitted in unsolicited form to CPDD. Editorials and reviews are considered by invitation only.

ACCP is pleased to announce that, in October 2012, it executed an agreement with Wiley Periodicals Inc to publish The Journal of Clinical Pharmacology and Clinical Pharmacology in Drug Development starting in January of 2013.

The Journal of Clinical Pharmacology

With its long-standing reputation for excellence, The Journal of Clinical Pharmacology (JCP) continues to be a premier publication in the field. For more than 50 years, clinical pharmacologists, clinical and pharmaceutical researchers, drug development specialists, physicians, nurses, and other medical professionals have relied on JCP for original research, special reviews, commentaries, and case reports on all phases of drug development from absorption, disposition, metabolism, excretion interactions, and preferred uses through post-marketing evaluations.

Ranked in the top 26% of journals in pharmacology and pharmacy and selected as one of the “Journals of the Century” (Journals of the Century, The Haworth Information Press, 2002), JCP continues to attract outstanding manuscripts that enhance its reputation for scientific excellence.

Publications

Student & Trainee Outreach

The Student Outreach Committee, comprised of ACCP Student Members, Members and Fellows, actively pursues programs to enhance the Student & Trainee experience in ACCP. These programs are designed to provide internships or career opportunities, awards recognition through competition for poster presentations, leadership within ACCP or its Student Chapters, and a mentoring program designed to provide guidance and support. Additionally, ACCP’s outstanding Continuing Education program encourages Student participation in educational meetings or online educational Workshops and Symposia on cutting-edge, relevant topics related to clinical pharmacology and the optimal use of therapeutics. These interactions provide a forum for new scientific ideas and bring together healthcare professionals of various disciplines to meet and discuss areas of common interest.

The ACCP Student Newsletter focuses entirely on the needs of Students & Trainees and includes interviews with clinical pharmacology experts and outstanding Student Members, pertinent educational articles and other materials.

The ACCP Annual Meeting is an excellent opportunity for Students & Trainees to participate by submitting an abstract, taking part in Poster Session tours of exceptional posters with senior ACCP Members and Fellows and attending the Student & Trainee Networking Reception, where they can interact individually or as a group with experienced clinical pharmacology professionals, ask questions and get expert advice.

ACCP is committed to facilitating the success of the chosen careers of Students & Trainees in clinical practice, academia, industry or regulatory agencies by providing support and guidance through its Mentoring Program. Each request for a Mentor is matched to a uniquely suitable Fellow or Senior Member capable of answering questions and guiding the Student or Trainee through challenging educational and career choices.

In addition to collegial exchange and networking opportunities, ACCP publishes The Journal of Clinical Pharmacology and the Clinical Pharmacology in Drug Development eJournal, both of which are provided to Student Members in electronic format at no additional cost.

2012 ANNUAL REPORT

11

American College of Clinical Pharmacology416 Hungerford Dr., Suite 300, Rockville, MD 20850

mailing address: PO Box 1637, Rockville, MD 20849phone: 240.399.9070

fax: 240.399.9071website: www.ACCP1.org